Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis

  • Ichiro Nakada
  • Hideyuki Ubukata
  • Yoshihisa Goto
  • Yoshinori Watanabe
  • Shigenori Sato
  • Takafumi Tabuchi
  • Tetsuo Soma
Case Report
Received:
Accepted:

Abstract

The management of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis (FAP) is very difficult. Non-steroidal anti-inflammatory drugs (NSAIDs), anti-estrogenic agents, and steroids are most commonly used, because surgical removal of these tumors may result in severe morbidity, with local recurrence being common. We report a patient with FAP and intra-abdominal desmoid tumors that regressed markedly after prednisolone therapy. The patient, a 38-year-old woman, had undergone total colectomy and ileorectal anastomosis with a diagnosis of FAP with colon cancer. Approximately 17 months after the surgery, she noticed an elastic firm lump in the abdominal wall. She also experienced lower abdominal distension. Computed tomography (CT) of the lower abdomen showed an invasive heterogenous low-density mass occupying the intra-abdominal space. She was treated with sulindac, NSAID, at 300 mg/day, the diagnosis being intra-abdominal desmoid tumors. She exhibited an intestinal obstruction about 9 months after the initiation of sulindac therapy. We changed the treatment and began prednisolone (initial dose, 40 mg/day). This treatment was continued for two years; subsequently the lesions regressed markedly. She is currently well, more than 3 years after the withdrawal of prednisolone.

Key words

intra-abdominal desmoid tumors familial adenomatous polyposis prednisolone therapy 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Bussey HJR. Familial polyposis coli; family studies, histopathology, differential diagnosis and results of treatment. Baltimore, Maryland: Johns Hopkins University Press, 1975;18–46.Google Scholar
  2. 2.
    Cambell WJ, Spence RA, Parks TG. Familial adenomatous polyposis. Br J Surg 1994;81:1722–1733.CrossRefGoogle Scholar
  3. 3.
    Belchetz LA, Berk T, Bapat BV, et al. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996;39:384–387.PubMedCrossRefGoogle Scholar
  4. 4.
    Philips RKS, Spigelman AD, Thomson JPS. Familial adenomatous polyposis and other polyposis syndromes. London: Edward Arnold, 1994:128–142.Google Scholar
  5. 5.
    Tsukada K, Church JM, Jagelman DG, et al. Systemic cytotoxic chemotherapy and radiation therapy for desmoids in familial adenomatous polyposis. Dis Colon Rectum 1991;34:1090–1092.PubMedCrossRefGoogle Scholar
  6. 6.
    Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33:639–642.PubMedCrossRefGoogle Scholar
  7. 7.
    Klemmer S, Pascoe L, DeCosse J. Occurrence of desmoids in patients with familial adenomatous polyposis of the colon. Am J Med Genet 1987;28:385–392.PubMedCrossRefGoogle Scholar
  8. 8.
    Jones IT, Fazio VW, Weakley FL, et al. Desmoid tumors in familial polyposis coli. Ann Surg 1986;204:94–97.PubMedCrossRefGoogle Scholar
  9. 9.
    Magid D, Fishman EK, Jones B, et al. Desmoid tumors in Gardner's syndrome: Use of computed tomography. AJR 1984;143:1141–1145.Google Scholar
  10. 10.
    Kitamura A, Kanagawa T, Yamada S, et al. Effective chemotherapy for abdominal desmoid tumor in a patient with Gardner's syndrome: Report of a case. Dis Colon Rectum 1991;34:822–826.PubMedCrossRefGoogle Scholar
  11. 11.
    Lynch HT, Fitzgibbons R Jr, Chong S, et al. Use of doxorubicin and dacarbazine for the management of unresectable intraabdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994;37:260–267.PubMedCrossRefGoogle Scholar
  12. 12.
    Waddell WR, Gerner RE, Reich MP. Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 1983;22:197–211.PubMedCrossRefGoogle Scholar
  13. 13.
    Tsukada K, Church JM, Jagelman DG, et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:29–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Panos TC, Poth E. Desmoid tumor of the abdominal wall: Use of prednisone to prevent recurrence in a child. Surgery 1959;45:777–779.PubMedGoogle Scholar
  15. 15.
    Umemoto S, Makuuchi H, Amemiya T, et al. Intra-abdominal desmoid tumors in familial polyposis coli: A case report of tumor regression by prednisolone therapy. Dis Colon Rectum 1991; 34:89–93.PubMedCrossRefGoogle Scholar
  16. 16.
    Mukherjee A, Malcolm A, Hunt M de la, et al. Pelvic fibromatosis (desmoid)—treatment with steroids and tamoxifen. Br J Urol 1995;75:559–560.PubMedCrossRefGoogle Scholar
  17. 17.
    Waddell WR, Kirsch WM. Testolactone, sulindac, warfarin and vitamin K1 for unresectable desmoid tumors. Am J Surg 1991;161:416–421.PubMedCrossRefGoogle Scholar
  18. 18.
    Reitamo J. The desmoid tumor: Choice of treatment, results and complications. Arch Surg 1983;118:1318–1322.PubMedGoogle Scholar
  19. 19.
    Berk T, Cohen Z, McLeod RS, et al. Management of mesenteric desmoid tumors in familial adenomatous polyposis. CJS 1992; 35:393–395.Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Ichiro Nakada
    • 1
  • Hideyuki Ubukata
    • 1
  • Yoshihisa Goto
    • 1
  • Yoshinori Watanabe
    • 1
  • Shigenori Sato
    • 1
  • Takafumi Tabuchi
    • 1
  • Tetsuo Soma
    • 1
  1. 1.Department of SurgeryTokyo Medical College Kasumigaura HospitalInashiki, IbarakiJapan

Personalised recommendations